Literature DB >> 22071970

In utero administration of Ad5 and AAV pseudotypes to the fetal brain leads to efficient, widespread and long-term gene expression.

A A Rahim1, A M Wong, S Ahmadi, K Hoefer, S M K Buckley, D A Hughes, A N Nathwani, A H Baker, J H McVey, J D Cooper, S N Waddington.   

Abstract

The efficient delivery of genetic material to the developing fetal brain represents a powerful research tool and a means to supply therapy in a number of neonatal lethal neurological disorders. In this study, we have delivered vectors based upon adenovirus serotype 5 (Ad5) and adeno-associated virus (AAV) pseudotypes 2/5, 2/8 and 2/9 expressing green fluorescent protein to the E16 fetal mouse brain. One month post injection, widespread caudal to rostral transduction of neural cells was observed. In discrete areas of the brain these vectors produced differential transduction patterns. AAV2/8 and 2/9 produced the most extensive gene delivery and had similar transduction profiles. All AAV pseudotypes preferentially transduced neurons whereas Ad5 transduced both neurons and glial cells. None of the vectors elicited any significant microglia-mediated immune response when compared with control uninjected mice. Whole-body imaging and immunohistological evaluation of brains 9 months post injection revealed long-term expression using these non-integrating vectors. These data will be useful in targeting genetic material to discrete or widespread areas of the fetal brain with the purpose of devising therapies for early neonatal lethal neurodegenerative disease and for studying brain development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22071970     DOI: 10.1038/gt.2011.157

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  19 in total

1.  In utero delivery of rAAV2/9 induces neuronal expression of the transgene in the brain: towards new models of Parkinson's disease.

Authors:  L Chansel-Debordeaux; M Bourdenx; S Dovero; V Grouthier; N Dutheil; A Espana; L Groc; C Jimenez; E Bezard; B Dehay
Journal:  Gene Ther       Date:  2017-11-16       Impact factor: 5.250

2.  Neonatal overexpression of estrogen receptor-α alters midbrain dopamine neuron development and reverses the effects of low maternal care in female offspring.

Authors:  Catherine Jensen Peña; Frances A Champagne
Journal:  Dev Neurobiol       Date:  2014-07-08       Impact factor: 3.964

3.  Lipoprotein lipase in hypothalamus is a key regulator of body weight gain and glucose homeostasis in mice.

Authors:  Elise Laperrousaz; Valentine S Moullé; Raphaël G Denis; Nadim Kassis; Chloé Berland; Benoit Colsch; Xavier Fioramonti; Erwann Philippe; Amélie Lacombe; Charlotte Vanacker; Noémie Butin; Kimberley D Bruce; Hong Wang; Yongping Wang; Yuanqing Gao; Cristina Garcia-Caceres; Vincent Prévot; Matthias H Tschöp; Robert H Eckel; Hervé Le Stunff; Serge Luquet; Christophe Magnan; Céline Cruciani-Guglielmacci
Journal:  Diabetologia       Date:  2017-04-29       Impact factor: 10.122

4.  Prenatal Gene Therapy for Metabolic Disorders.

Authors:  Barbara Coons; William H Peranteau
Journal:  Clin Obstet Gynecol       Date:  2021-12-01       Impact factor: 1.966

5.  Viral transduction of the neonatal brain delivers controllable genetic mosaicism for visualising and manipulating neuronal circuits in vivo.

Authors:  Ji-Yoen Kim; Ryan T Ash; Carolina Ceballos-Diaz; Yona Levites; Todd E Golde; Stelios M Smirnakis; Joanna L Jankowsky
Journal:  Eur J Neurosci       Date:  2013-01-24       Impact factor: 3.386

6.  Virus-Mediated Genome Editing via Homology-Directed Repair in Mitotic and Postmitotic Cells in Mammalian Brain.

Authors:  Jun Nishiyama; Takayasu Mikuni; Ryohei Yasuda
Journal:  Neuron       Date:  2017-10-19       Impact factor: 17.173

Review 7.  A narrative review of in utero gene therapy: advances, challenges, and future considerations.

Authors:  Nicholas K Yung; Nathan L Maassel; Sarah J Ullrich; Adele S Ricciardi; David H Stitelman
Journal:  Transl Pediatr       Date:  2021-05

8.  Fetal Brain-directed AAV Gene Therapy Results in Rapid, Robust, and Persistent Transduction of Mouse Choroid Plexus Epithelia.

Authors:  Marie Reine Haddad; Anthony Donsante; Patricia Zerfas; Stephen G Kaler
Journal:  Mol Ther Nucleic Acids       Date:  2013-06-25       Impact factor: 10.183

9.  Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brain.

Authors:  Paramita Chakrabarty; Awilda Rosario; Pedro Cruz; Zoe Siemienski; Carolina Ceballos-Diaz; Keith Crosby; Karen Jansen; David R Borchelt; Ji-Yoen Kim; Joanna L Jankowsky; Todd E Golde; Yona Levites
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

Review 10.  The Future of In Utero Gene Therapy.

Authors:  William H Peranteau; Alan W Flake
Journal:  Mol Diagn Ther       Date:  2020-04       Impact factor: 4.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.